Endo International Ordinary Shares reported $2.49B in Current Assets for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Assets Change
Abbvie ABBV:US $ 26509M 1419M
Aerie Pharmaceuticals AERI:US $ 355.65M 79.7M
Amarin AMRN:US $ 772.62M 106.11M
Coherus Biosciences CHRS:US $ 512.44M 89.88M
Endo International Ordinary Shares ENDP:US $ 2492.79M 221.79M
Heron Therapeutics HRTX:US $ 222.59M 31.83M
Hikma Pharmaceutical HIK:LN 2.09B 139M
Horizon Pharma HZNP:US $ 2947.73M 147.96M
JAZZ PHA JAZZ:US $ 2500.86M 110.48M
Ligand Pharmaceuticals LGND:US $ 276.07M 188.68M
Merk MRK:US $ 31184M 918M
Novartis NOVN:VX 37.24B 8.48B
Patterson Companies PDCO:US $ 1790.43M 9M
Phibro Animal Health PAHC:US $ 546.48M 37.87M
Takeda 4502:JP Y 2593642M 115749M
Teva Pharmaceutical TEVA:IT 12.57B 419M
Zoetis ZTS:US $ 6930M 248M